Rankings / Metabolic Health

Aspirin (low-dose)

Metabolic Health · Irreversible COX-1 inhibitor

Tier B

cox-pathwayotc
6.8 / 10
Tier B
Ev 8 Bn 8 Sf 5

Bottom line

Read Off Label grades Aspirin (low-dose) as B (6.8/10) based on strong evidence, strong benefit magnitude, and a med-risk safety profile.

USPSTF 2022 updated: aspirin for primary prevention in ages 40-59 with ≥10% 10-yr ASCVD risk is a Grade C (individualized decision); against for ≥60.

Typical use: 75-100 mg/day PO (81 mg standard in US) — OTC.

What this is

USPSTF 2022 updated: aspirin for primary prevention in ages 40-59 with ≥10% 10-yr ASCVD risk is a Grade C (individualized decision); against for ≥60. Still a cornerstone in secondary prevention. The biohacker default of 'take it just in case' is no longer supported in most healthy people.

Mechanism

Irreversible acetylation of platelet COX-1 for lifetime of platelet; prevents thromboxane A2 synthesis → reduced platelet aggregation

Dose & route

75-100 mg/day PO (81 mg standard in US)

Common questions

Does Aspirin (low-dose) work?
Read Off Label rates the evidence for Aspirin (low-dose) as Strong and the benefit magnitude as strong, producing an overall grade of B (6.8/10). USPSTF 2022 updated: aspirin for primary prevention in ages 40-59 with ≥10% 10-yr ASCVD risk is a Grade C (individualized decision); against for ≥60.
Is Aspirin (low-dose) safe?
Aspirin (low-dose) has a med risk profile in published human data. Legal status: OTC. This is not medical advice — see the disclaimer.
What is the typical dose for Aspirin (low-dose)?
75-100 mg/day PO (81 mg standard in US)
How does Aspirin (low-dose) work?
Irreversible acetylation of platelet COX-1 for lifetime of platelet; prevents thromboxane A2 synthesis → reduced platelet aggregation

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.